Keyword: David Ricks

Lilly CEO David Ricks, in his second year on the job, hauled in a pay package larger than those of a few of his big pharma peers.

The move comes as Lilly and the other two big diabetes drugmakers face increasing political pressure on rising insulin prices.

Sweep out drug rebates for patient discounts instead? Supply chain players hate the idea, but Big Pharma CEOs are all over it.

Eli Lilly is the first pharma to add pricing information to its DTC TV advertising in a commercial for Trulicity this week, with more on the way.

Big biopharma CEOs gave most or all their campaign contributions to Republicans this season, but one went full blue with his $120,000.

After HHS proposed a rule that would shake up or eliminate drug rebates, a watchdog wants to know if agency chief Alex Azar has ulterior motives.

Lilly CEO David Ricks says casting off Elanco will allow it to allocate more capital to its human health efforts.

Lilly analysts worry growth could suffer if it doesn't win a nod for both baricitinib doses—and an FDA panel shot down one of them Monday.

Jockeying for market share, Eli Lilly offered more than half off its U.S. list prices in the form of rebates and discounts last year.

Former Eli Lilly CFO Derica Rice becomes the second top Big Pharma ex to take the reins at a major pharmacy benefit manager.